Overview

Pharmacokinetics of Metronidazole Dermal Products

Status:
Completed
Trial end date:
2021-03-05
Target enrollment:
Participant gender:
Summary
Generate human PK data by collecting data following the application of metronidazole formulations.
Phase:
Early Phase 1
Details
Lead Sponsor:
University of Maryland
University of Maryland, Baltimore
Collaborator:
Food and Drug Administration (FDA)
Treatments:
Metronidazole